Context Capital Management, LLC has filed its 13F form on August 09, 2024 for Q2 2024 where it was disclosed a total value porftolio of $330,000 distributed in 222 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Monterey Capital Acquisition Corp with a value of $80K, Bannix Acquisition Corp. with a value of $48K, Inception Growth Acquisition LTD with a value of $37K, Monterey Cap Acquisition Corp with a value of $31K, and Rf Acquisition Corp Rt with a value of $29K.
Examining the 13F form we can see an decrease of $420K in the current position value, from $750K to 330K .
Below you can find more details about Context Capital Management, LLC portfolio as well as his latest detailed transactions.
ETFs: $67,000
Financial Services: $56,000
Healthcare: $3,000
Basic Materials: $0
Stock
Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 99.92%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 99.81%
-
$0
0.0% of portfolio
-
Q2 2024
Added 28.89%
Two Harbors Inventment Corpo
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 99.9%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 7.91%
-
$0
0.0% of portfolio
-
Q2 2024
Added 5.19%
-
$0
0.0% of portfolio
-
Q2 2024
Added 41.25%
-
$0
0.0% of portfolio
-
Q2 2024
Added 700.0%
-
$0
0.0% of portfolio
-
Q2 2024
Added 35.98%
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 91.06%
-
$0
0.0% of portfolio
-
Q2 2024
Added 21.58%
-
$0
0.0% of portfolio
-
Q2 2024
Added 1.48%
-
$0
0.0% of portfolio
-
Q1 2022
New
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 99.9%
-
$0
0.0% of portfolio
-
Q2 2024
Added 25.66%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 68.78%
-
$0
0.0% of portfolio
-
Q2 2024
Added 30.35%
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 51.54%
Bridger Aerospace Grp Hldgs
-
$0
0.0% of portfolio
-
Q1 2023
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 33.21%
Bread Financial Holdings Inc
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 30.16%
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 9.7%
-
$0
0.0% of portfolio
-
Q2 2024
Added 80.84%
-
$0
0.0% of portfolio
-
Q2 2024
New
Cardio Diagnostics Holdgs In
-
$0
0.0% of portfolio
-
Q1 2023
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 76.75%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 99.9%
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
New
Conduit Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2023
New
Collegium Pharmaceutical Inc
-
$0
0.0% of portfolio
-
Q2 2024
Added 7.35%
-
$0
0.0% of portfolio
-
Q2 2024
Added 3.36%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 7.93%
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 14.42%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 38.99%
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 6.97%
-
$0
0.0% of portfolio
-
Q2 2024
Added 248.66%
-
$0
0.0% of portfolio
-
Q1 2022
New
-
$0
0.0% of portfolio
-
Q2 2024
Added 65.14%
-
$0
0.0% of portfolio
-
Q2 2024
Added 10.26%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
Reduced 53.33%
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 99.93%